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ess: efrgeorge@freemaSummary Purpose: The purpose of this study was to examine exercise tolerance in
patients with COPD from measurements of resting pulmonary function para-
meters.
Methods: A total of 57 COPD patients were administered the pulmonary function
test (PFT) and cardiopulmonary exercise test. The results were analyzed and
essentially linear relationships emerged when each subject’s VO2 peak was plotted
against his individual PFT parameters. Those significant contributors were then
introduced in a stepwise multiple regression analysis to determine the best predictor
of the VO2 peak.
Results: Stepwise multiple regressions in variables revealed that peak oxygen
consumption (VO2 peak) was predicted best by the following equation: VO2
peak=(maximum voluntary ventilation 0.024)+(forced mid-expiratory
flow 0.47)+(body surface area 0.988)0.913 (r ¼ 0:90; r2 ¼ 0:81 SE=0.29 L/
min).
Conclusion: We conclude that exercise capacity was predicted from measure-
ments of resting pulmonary function parameters with excellent accuracy in the
COPD patient.
& 2004 Elsevier Ltd. All rights reserved.Introduction
Exercise tolerance in patients with COPD has
multiple determinants and is difficult to predict
from measurements of resting pulmonaryElsevier Ltd. All rights reserv
2610 999523.
il.gr (K. Spiropoulos).function.1 Measurements of maximum exercise
tolerance have been reported to be useful in
disability evaluation2 and determination of the
cause of exertional symptoms.3,4 In addition,
understanding the factors which predict exercise
capacity will provide clues to a better under-
standing of physical activity limitations in patients
with COPD.ed.
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Table 1 Selected characteristics for 57 patients
with COPD*.
Male/female 44/13
Age (yr) 60711
Height (cm) 16778
Weight (kg) 73716
BSA (m2) 1.8270.2
Pack years (yr) 53724.3
Pulmonary function parameters (Percentage
predicted
normal)
FEV1 (L) 1.370.6 47.7%
FVC (L) 2.2371 66.5%
FEV1/FVC (%) 55.7
PEFR (L) 3.671.7 49.6%
FEF2575 (L/s) 0.870.5 27.9%
MVV (L/min) 46.2725 37.9%
TLC (L) 7.5471.7 125%
RV (L) 4.871.8 210%
G. Efremidis et al.610Previous studies in patients with COPD have
indicated that ventilatory limitation is a primary
determinant of exercise tolerance.4,5 However,
individual pulmonary function parameters as FEV1
explain only about half of the variance in measured
exercise tolerance.6,7
For many patients with COPD, psychosocial
characteristics may interact with physiologic ab-
normalities to limit physical work capacity. To date,
few published studies have closely examined the
role of psychosocial variables in the prediction of
peak VO2 in patients with COPD.
This study uses data from a clinical trial of
rehabilitation in COPD. The purposes of the analysis
were the following: to examine how well exercise
tolerance, specifically VO2 peak, can be predicted
from a combination of physiologic and psychosocial
measurements, and to provide insight into factors
determining and limiting exercise capacity in COPD
patients.IC (L) 1.9671 51%
Arterial partial pressure of O2 and CO2
PaO2 (mmHg) 75.579
PaCO2 (mmHg) 39.574
SatO2 (%) 9572
Definition of abbreviations: COPD=chronic obstructive
pulmonary disease; BSA=Body surface area; FEF2575=-
Forced midexpiratory flow; MVV=maximal voluntary ven-
tilation; IC=inspiratory capacity; SatO2=saturation of
arterial Oxygen.
*Values are mean7SD.Methods
Patient selection: All the patients recruited from
the outpatient clinic before had started the
rehabilitation program. We studied 57 clinically
stable COPD patients according to GOLD criteria.1
All patients signed the informed consent form. The
patients were clinically stable and had been
receiving optimal medical therapy for at least 8
weeks when they were examined, and had no
exacerbation for at least 12 weeks. Patients were
excluded if they had: a history suggesting asthma
(according to GINA criteria for asthma),8 atopy or
nasal polyps, a 15% or higher-increase FEV1 after
bronchodilator, active heart disease, musculoske-
letal disorders, peripheral vascular diseases or
other disabling conditions that would interfere
with the tests and could contribute to dyspnea or
exercise limitation. All patients had a basal set of
spirometry within the last year at our pulmonary
function laboratory. The baseline characteristics of
the patients are shown in Table 1.
Study design: COPD subjects included patients
who had performed pulmonary function tests (PFTs)
and incremental cycle exercise test during assess-
ment before pulmonary rehabilitation. Subjects
were familiarized with all procedures prior to
collection of the test results evaluated in this
study, and underwent baseline assessment with
extensive physiologic and psychosocial tests, prior
to beginning the clinical trial.
Equipment procedures: Anthropometric and body
composition. Body height (cm) was measured withsubjects standing barefoot and was determined to
the nearest 0.5 cm. Total body mass (kg) was
measured with subjects in light clothing and was
established to the nearest 0.1 kg. body surface area
(BSA) was measured with Dubois formula:
BSA=0.007184weight0.425 height0.725.9 This for-
mula has remained the standard for calculating BSA.9
PFTs: Each patient underwent PFT including:1. Spirometry was performed prior to exercise
testing, in accordance with the recommended
techniques (using a Pulmolab 435 Morgan Data
Acquisition System Ver.401).10 The subjects
completed at least three acceptable maximal
forced expiratory maneuvers. Technical proce-
dure acceptability and reproducibility criteria
were those recommended by the American
Thoracic Society.10 The predicted normal
values for spirometry were those of Morris and
associates.112. Maximal voluntary ventilation (MVV) was
performed before exercise testing. MVV was
directly determined with the subjects using nose
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Prediction exercise capacity in COPD 611clips and breathing deeply (with a volume
greater than the tidal volume preceding the
maneuver but less than the vital capacity) and
rapidly for a 12-s interval (Pulmolab 435 Morgan
Data Acquisition System Ver.401). The subjects
were actively encouraged to maintain the same
volume and frequency by following an online
display of the maneuver on a computer screen,
that is, the end expiratory level remained
relatively constant. At least two acceptable
maneuvers were obtained with values differing
by no more than 10% and after flow integration,
the highest value recorded by extrapolating the
12-s accumulated volume to 1min (L/min,
BTPS).3. Lung volumes were determined in a constant
volume whole body plethysmography (Master
Screen Body, Jaeger, Version 4, 5) before
exercise testing. The subjects completed at
least three acceptable maneuvers. The predic-
tive values for lung function parameters were
derived from those published by the ATS.12,134. Arterial blood gases: Arterial blood gas (PaO2
and PaCO2) and pH were measured at rest,
before exercise testing, while breathing room
air, using a blood gas analyzer (Eschweiler
system 2000).5. Exercise test: The exercise tests (maximal
incremental cycle ergo meter protocol) were
performed on a manual braked cycle ergometer
(Pulmolab 505, Exercise test system VS B.42)
with the subjects maintaining a pedaling fre-
quency of 60+5 rpm.5 All tests were proceeding
by a 1-min baseline of ‘‘true’’ unloaded pedal-
ing, that is, by means of motor-assisted pedaling
during this phase. After that exercise began at
25W for 1min, with 25W increments every
minute until exhaustion. Normally an increase
of 5–10W is appropriate when testing COPD
patients. But Debigare et al.14 conclude that the
work rate incremental rate influences only the
Wpeak achieved, whereas the peak value for
VO2 remains comparable. Subjects breathed
through a mouthpiece with nose clips in place.
Arterial oxygen saturation was monitored con-
tinuously by finger oxymetry. Electrocardiogra-
phy and pulse oxymetry were monitored
continuously during the exercise test and blood
pressure was taken manually at periodic inter-
vals. Expired gases were monitored and ana-
lyzed by computer for calculation of VE, VO2,
VCO2 and VD/VT (as calculated from measure-
ment PaCO2 and PECO2). Peak exercise was
defined as the highest work level reached during
the incremental exercise test. Patients were
included in the analysis without respect to sub-maximal effort, cardiac rate limitation, or
ventilatory limitation to exercise. The subjects
were actively encouraging every 30 s using two
phrases ‘‘You are doing well’’ or ‘‘Keep up the
good work’’. Exercise in the COPD subjects was
terminated by any one of the following events:
a. Subjective complaints (severe dyspnea, fati-
gue, dizziness, or chest pain);
b. ECG abnormalities (ST changes, frequent
ectopic beats).Exercise responses were compared with the
predicted normal values of ATS5 and ventilation
(VE) was compared with the predicted maximal
ventilatory capacity of Dillard and associates.15
Psychosocial: The following psychosocial mea-
surements were included in this analysis:1. Quality of life was assessed using the Saint
George’s Respiratory Questionnaire.162. Depression and anxiety was assessed using the
Greek version of the Hospital Anxiety and
Depression Scale.17
Statistical analysis
PFT and exercise variables were expressed as
means and standard deviations. Relationships be-
tween PFT and exercise variables were assessed
using the Pearson product moment correlation (R).
Correlation between QoL and physiological mea-
sures were done using the non-parametric Kendall
concordance test. The statistical significant was set
at Po0:05: Stepwise multiple regression (r2) was
performed on the 57 patients to determine the best
predictors of peak VO2 from independent variables
(see Table 2 and 3). Computations were made with
SPSS 10.1 program.
This analysis identified tree variables as the best
combination of predictors of peak VO2 (MVV,
FEF2575, and BSA).Results
A total of 57 COPD patients signed informed
consent and entered the study. We studied 44 male
and 13 female patients. The anthropometric data
are presented in Table 1.
Physiologic parameters
Correlations between pulmonary function and
exercise test results (VO2 peak) are presented in
Table 2, which many variables of PFT correlated
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G. Efremidis et al.612statistically significant with the VO2 peak. The
stepwise multiple regression analysis to predict
peak VO2 from 57 patients elucidates that the best
predictor was MVV (describe the 62% in total
fluctuation of VO2 peak, F ¼ 46:8; Po0:001).
FEF2575 plus 13% in total fluctuation (F ¼ 14:3;
P ¼ 0:001) and BSA were responsible for 6.5% in
total fluctuation (F ¼ 9:4; P ¼ 0:005). The total
prediction from the three aforementioned predic-
tors was 81.5%. Using only these variables asTable 2 Correlation between VO2 peak and
resting pulmonary function parameters in 57
patients.
Variable COPD N ¼ 57
VO2 peak
Static lung volume R P
VC 0.767 o0.001
IC 0.811 0.001
FRC 0.408 0.028
TV 0.430 0.020
Ventilatory output
MVV 0.631 o0.001
Spirometry
FVC 0.710 o0.001
FEV1 0.619 o0.001
PEFR 0.647 o0.001
FIF50 0.635 o0.001
PIFR 0.678 o0.001
FEF25 0.474 0.009
FEF75 0.404 0.030
FEF2575 0.381 0.041
FEF50 0.345 NS
Anthropometric
BSA 0.683 o0.001
Weight 0.502 0.006
Arterial sample
PH 0.219 NS
PaO2 0.193 NS
PaCO2 0.219 NS
Table 3 Stepwise multiple regression analysis to pre
variables), n ¼ 57:
Variable examined Multiple R Adjusted R2 Unstandardize
b S
MVV 0.79 0.62 0.024 0
FEF2575 0.87 0.75 0.470 0
BSA 0.90 0.81 0.988 0independent variables, the best regression equa-
tion to predict peak VO2 was the following equation
(n ¼ 57):
PeakVO2ðL=minÞ ¼ ðMVV 0:024Þ þ ðFEF25
75 0:47Þ þ ðBSA 0:988Þ  0:913 (r ¼ 0:90; r2 ¼
0:81; SE=0.29 L/min).
All the aforementioned data are presented in
Table 3.
Quality of life
Correlation between quality of life and the VO2
peak is presented in Table 4. The VO2 peak
correlated significant primarily with activities
(r ¼ 0:503). Total scores (0.409) of SGRQ, symp-
toms (r ¼ 0:407) and impacts (r ¼ 0:298) correlated
less than the activities.
HADs score and VO2 peak were not correlated
significant as presented in Table 4.Discussion
The results of this study demonstrate that peak VO2
can be predicted with excellent accuracy (r ¼ 0:90;dict VO2 peak (including only statistical significant
d coefficients Standardized coefficients t Sig.
td error b
.03 0.85 7.13 0.000
.13 0.37 3.56 0.001
.32 0.30 3.06 0.005
Table 4 Relationship between SGRQ scores and
HADs score with VO2 peak (n ¼ 57).
SGRQ score,
% of total
disability
VO2 peak
r P value
Symptoms 40 0.407 0.026
Activities 52 0.503 0.005
Impacts 35 0.298 0.05
Total Score 41 0.409 0.013
HANDs score,
% of total
disability
Anxiety 30 0.120 0.333
Depression 19 0.187 0.285
Total score 27 0.106 0.346
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independent variables utilized in this analysis. The
combination of independent variables found to be
most predictive of peak VO2 was MVV, FEF2575, and
BSA.
The reasons for trying to predict peak VO2 from
measures of resting pulmonary function are multi-
ple. Patients could possibly save time, expense,
and invasive procedures if an accurate prediction of
their maximum exercise tolerance could be made
based upon resting pulmonary function parameters.
Also, this knowledge may help the patient to get
advice about how to do exercises or to be physically
active. Reasonably accurate prediction equations
could also be used to determine if the measured
peak VO2 is consistent with the patient’s physiolo-
gic status. This might indicate a need for further
evaluation of the patient, with ‘‘unexplained’’
exercise limitation in an individual whose exercise
tolerance is reduced out of proportion to that
predicted from the resting pulmonary function.
This might be especially helpful in the area of
disability evaluation.
None of the psychosocial variables measured in
this study were found to be significant predictors of
peak VO2 once variance associated with physiologic
variables was removed. Using multiple regression
analysis, Mahler and Harver6 found that the base-
line dyspnea index was an important predictor of
peak VO2 in a group of patients with COPD. In the
present study, neither the measures of SGRQ nor
measures of HADs added significantly to the overall
prediction equation. The correlations between
individual predictor variables and peak VO2 were
only slightly lower in the present study than those
reported in the study of Mahler and Harver.6
Most similar published studies have examined
only patients with COPD.6,18–21 The methodology
used in these studies was similar to that used in the
present one, namely multiple regression analysis of
different parameters of resting and exercise pul-
monary function to generate one or more predic-
tion equations of either peak VO2. Differences in
results could be related to differences in patients
(e.g., disease severity) and to the specific variables
examined. For instance, the degree of expiratory
obstruction is variable in these studies, with the
mean FEV1, between 1.22 and 1.85 L, and the
prediction equations explained between 79% and
91% of the variance in measured peak VO2.
Dillard et al. demonstrated a strong relationship
between peak VO2 and MIP as well as power output,
VE max DCO and FEV1. This relationship led the
authors to conclude that inspiration strength may
be an important determinant of exercise capacity
in COPD patients. In our prediction equation MVVmay well explain the variance in peak VO2
accounted for by MIP and FEV1, as MVV depends
upon both inspiration and expiration.
In addition, it is well known that the expiratory
airflow limitation is the hallmark of physiological
change of COPD.1 The sites of airflow limitation in
COPD are the smaller conducting airways (less than
2mm in internal diameter).1 FEF2575 constitutes
the parameter that is determined by spirometry,
which gives an average flow over the mid-portion of
the spirogram. McFarden et al.22 postulated that
low FEF2575 represents the significant obstruction in
peripheral bronchioles, despite the variance of
FEF2575 being generally about 40%, our analysis
distinguishes this parameter as the second best
predictor. Perhaps, FEF2575 represents a more
sensitive parameter such as Obliterative Bronchio-
litis.22,23
The last variable that contributes to our equation
is BSA. It is well known that the absolute VO2 peak
is strongly influenced by change in body size.5 For
that reason, the appropriate adjustment of this
parameter for body size should help to explain the
impact of other factors. BSA is utilized to measure
the metabolic rate in a clinical setting. Obese
people have higher total daily energy expenditures
because of the excess fat they have to transport
when active. Because of the increased metabolic
rate to perform a certain amount of external work,
i.e., work to move larger body mass, there must be
greater than normal cardiorespiratory response to
exercise.4 Perhaps BSA contributes to normalizing
our equation.
Previous studies found a moderate correlation
between maximal exercise capacity and the resting
IC24,25 but only in patients with flow limitations. In
our patients, there was no significant correlation of
VO2 peak to IC, because our study may be
concluded in flow and non-flow limitation patients.
In summary, maximum exercise tolerance is
predicted reasonably well from measurements of
resting pulmonary function in these COPD patients.
The most consistent predictors of VO2 peak were
measurements of expiratory airflow limitation
(FEF2575) and inspiratory–expiratory strength
(MVV); none of the psychosocial variables added
significantly to the accuracy of the prediction of
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